XML 129 R111.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           $ 1,584,652 $ 1,450,826 $ 1,381,842
Total consolidated adjusted operating income           308,778 287,570 267,602
Deferred revenue adjustment               (8,561)
CEO transition costs               (6,195)
Restructuring expense           (1,870) (18,817) (25,628)
Business acquisition and integration expense           (34,215) (42,661) (53,198)
Litigation reserve           18,500 10,000  
Loss on assets held for sale           (647) 0 0
Debt modification costs           (848)    
Gain on sale of assets           0 13,317 0
Total consolidated operating income           217,054 168,170 76,746
Interest expense           (63,659) (63,100) (129,348)
Other income, net           10,542 6,965 1,108
Total consolidated income from continuing operations before income taxes           163,937 112,035 (51,494)
Total Consolidated capital expenditures           48,893 26,014 31,054
Total consolidated depreciation expense $ 9,338 $ 19,381 $ 21,427 $ 29,879 $ 31,506 39,676 41,376 44,574
Total consolidated intangible amortization expense           (35,644) (61,239) (97,274)
Chamberlain                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           633,522 571,034 557,536
Walden University                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           595,332 533,725 485,393
Medical and Veterinary                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           355,798 346,067 338,913
Operating Segments [Member] | Chamberlain                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           633,522 571,034 557,536
Total consolidated adjusted operating income           137,800 135,503 127,252
Total Consolidated capital expenditures           26,293 13,934 15,235
Total consolidated depreciation expense           18,752 17,175 18,547
Operating Segments [Member] | Walden University                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           595,332 533,725 485,393
Total consolidated adjusted operating income           130,547 110,364 104,582
Total Consolidated capital expenditures           5,889 1,084 5,393
Total consolidated depreciation expense           7,389 9,419 9,255
Total consolidated intangible amortization expense           (35,644) (61,239) (97,274)
Operating Segments [Member] | Medical and Veterinary                
Segment Reporting Information [Line Items]                
Total Consolidated Revenue           355,798 346,067 338,913
Total consolidated adjusted operating income           71,507 67,336 69,148
Restructuring expense           (442) (7,687) (9,791)
Total Consolidated capital expenditures           5,708 3,358 3,277
Total consolidated depreciation expense           11,983 12,438 13,890
Corporate, Non-Segment [Member]                
Segment Reporting Information [Line Items]                
Total consolidated adjusted operating income           (31,076) (25,633) (33,380)
Total Consolidated capital expenditures           11,003 7,638 7,149
Total consolidated depreciation expense           $ 1,552 $ 2,344 $ 2,882